Replies to post #108439 on Biotech Values

[mcbio]

ANDS must truly be desperate to be talking about resuscitating ANA773, the TLR7 modulator that ANDS effectively discontinued 1.5 years ago (#msg-38418158). I completely discount the potential for ANA773 to be a meaningful drug in HCV.

I.e., ANDS now has two drug candidates subject to Zebra's Law?